Literature DB >> 303996

Enhancing effect of low dose cyclophosphamide treatment on the in vitro antibody response.

H Duclos, P Galanaud, O Devinsky, M C Maillot, J Dormont.   

Abstract

We have studied the effect of cyclophosphamide (CY) administration on the subsequent in vitro antibody response in the mouse. Treatment with a low dose (20 mg/kg) of CY four days before culture results in an increased IgM response to the T-independent antigen trinitrophenylated polyacrylamide (TNP-PAA), without affecting the background response of unstimulated cultures. This suggests that CY treatment eliminates a short-lived suppressor cell, involved in the regulation of the in vitro B cell response. In contrast, the same regimen decreases the ability of nude mouse spleen cells to respond to TNP-PAA, showing that the target of CY-enhancing effect is a mature T cell. The increased response observed in conventional mice should be the result of a balance between the direct suppressive effect of CY on B cells and the elimination of a suppresor T cell, the latter phenomenon being of predominant significance in our conditions. The target of CY-enhancing effect is nonadherent to plastic, but adherent to Sephadex G-10 columns.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 303996     DOI: 10.1002/eji.1830071005

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Appearance of Guillain-Barré syndrome in patients during corticosteroid treatment.

Authors:  I Steiner; I Wirguin; O Abramsky
Journal:  J Neurol       Date:  1986-08       Impact factor: 4.849

2.  Regulation of the immune response to tumor antigen.

Authors:  M I Greene; L L Perry; B Benacerraf
Journal:  Am J Pathol       Date:  1979-04       Impact factor: 4.307

3.  Modulation of the immune system in the mouse. 1. Drug administration prior to antigen sensitization.

Authors:  J Cottney; J Bruin; A J Lewis
Journal:  Agents Actions       Date:  1980-09

4.  Differential effects of azathioprine on T cells regulating murine B-cell function.

Authors:  H Duclos; M C Maillot; P Galanaud
Journal:  Immunology       Date:  1982-07       Impact factor: 7.397

5.  Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.

Authors:  H C Stevenson; A S Fauci
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

6.  Priming of T helper cells by antigen-activated B cells. B cell-primed Lyt-1+ helper cells are restricted to cooperate with B cells expressing the IgvH phenotype of the priming B cells.

Authors:  J L'Age-Stehr
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.